Direct Determination of Platelet-Produced Thromboxane B2 in Human Serum by Column-Switching High-Performance Liquid Chromatography with Fluorescence Detection.

DOI PDF Web Site Web Site Web Site 17 References

Search this article

Abstract

A high-performance liquid chromatographic method for the direct determination of platelet-produced thromboxane B2 in human serum is described. The method is based on direct derivatization of the thromboxane B2 in human serum with 6,7-dimethoxy-1-methyl-2(1H)-quinoxalinone-3-propionyl carboxylic acid hydrazide. The derivatization reaction proceeds in aqueous solution (or serum sample) in the presence of pyridine and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide at 37°C. The resulting fluorescent derivative of thromboxane B2 is separated by column-switching chromatography using a first column (YMC-Pack C4) for the trap and clean-up of the derivative and a second column (YMC-Pack Ph) for complete separation of the derivative. The derivative is detected spectrofluorometrically at 445 nm with excitation at 367 nm. The detection limit (signal to noise ratio=3) for thromboxane B2 is 10 pmol (3.7 ng)/ml serum. The present method is highly sensitive and simple without any clean-up, such as in conventional liquid-liquid and solid-phase extraction.

Journal

  • Analytical Sciences

    Analytical Sciences 16 (1), 45-48, 2000

    The Japan Society for Analytical Chemistry

References(17)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top